Implantologijos klinika Dentzz, UAB - financials and debts
Company age: 6 y. 1 mo.
Implantologijos klinika Dentzz - Company finances
|
EUR
|
2020
From: 2020-08-27
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | 508,752 | 633,781 | 713,131 | 614,478 | 514,382 |
| Profit before tax | -1,811 | 22,453 | 8,522 | 243,348 | 3,077 | -7,121 |
| Net profit | -1,811 | 19,124 | 7,316 | 241,203 | 2,667 | -7,121 |
| Equity | 689 | 19,813 | 27,129 | 40,037 | 42,691 | 35,570 |
| Liabilities | 18,511 | 67,404 | 100,672 | 81,882 | 66,794 | 81,408 |
| Non-current assets | 14,373 | 15,212 | 35,638 | 27,073 | 20,324 | 10,955 |
| Current assets | 4,827 | 72,005 | 91,737 | 94,408 | 89,161 | 106,023 |
| Total assets | 19,200 | 87,217 | 127,375 | 121,481 | 109,485 | 116,978 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 34,666 | 36,141 | 28,538 |
| Social insurance contributions | - | - | - | 39,729 | 41,619 | 33,823 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | +24.6% | +12.5% | -13.8% | -16.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -9.4% | 21.9% | 5.7% | 198.6% | 2.4% | -6.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -262.8% | 96.5% | 27.0% | 602.5% | 6.2% | -20.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 3.8% | 1.2% | 33.8% | 0.4% | -1.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 4.4% | 1.3% | 34.1% | 0.5% | -1.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 26.9 | 3.4 | 3.7 | 2.0 | 1.6 | 2.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 91,741 | 93,893 | 79,977 | 71,590 | 67,831 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Implantologijos klinika Dentzz - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-17 | 2026-07-06 | 42.29 |
| 2026-06-16 | 2026-06-16 | 37.40 |
| 2026-05-17 | 2026-05-25 | 422.83 |
| 2025-09-07 | 2025-09-14 | 16.34 |
| 2025-08-31 | 2025-09-03 | 16.34 |
| 2025-08-19 | 2025-08-29 | 16.34 |
| 2025-07-24 | 2025-08-12 | 17.05 |
| 2025-07-16 | 2025-07-23 | 16.54 |
| 2025-06-17 | 2025-06-25 | 189.84 |
| 2025-03-18 | 2025-04-14 | 0.05 |
| 2025-02-18 | 2025-03-13 | 0.44 |
| 2025-01-22 | 2025-02-16 | 7.02 |
| 2024-12-22 | 2024-12-29 | 2336.86 |
| 2024-12-17 | 2024-12-20 | 2336.86 |
| 2022-12-16 | 2022-12-19 | 2429.56 |
Implantologijos klinika Dentzz - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-17 | 2025-05-20 | 0.55 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Implantologijos klinika Dentzz, UAB is a Private Limited Liability Company (code 305613120) engaged in dental practice care activities. In 2025, the company generated revenue of €514.4K and reported a net loss of €7.1K, corresponding to a profit margin of -1.4%. This followed a clear downward trajectory from 2024, when revenue was €614.5K and net profit €2.7K, and from 2023, when revenue reached €713.1K and net profit was €241.2K. Over the two-year period, revenue declined by 27.9% and by 16.3% year on year in 2025. The balance sheet remained moderate in size, with total assets of €117.0K at the end of 2025, compared with €109.5K in 2024 and €121.5K in 2023. Equity stood at €35.6K and liabilities at €81.4K, indicating a debt-to-equity ratio of 2.29 and an equity ratio of 30.4%. Asset turnover was 4.40x. Revenue per employee was €73.5K, while profit per employee was negative in 2025.